Nectar Lifesciences Limited

₹10.28As of Sun 8 Nov 2026, 12:00 UTC
NSE:NECLIFEHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (11.51%)
Div yield —
ROE (7.46%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.63
PE TTM —
TSR TTM (33.72%)
Mkt cap ₹1.997B
ROIC (16.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹10
(1.75%)
(68.58%)
Hold 12|3|7|9|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.12
0.12
0.11
0.12
9.87%
9.95%
3.48%
(2.01%)
Revenue₹M
146.6
144.1
141.5
148.4
8.19%
5.28%
3.24%
3.26%
Peers (US$20.93M)
Cap (US$)
PE
19.78M
2.549x
20.61M
3.497x
Capital
TTM
5Y
10Y
Leveragex
0.426
(0.651)
(0.693)
EBIT/Intx
1.962
2.703
1.620
Own earn%
12.03
0.04
2.91
Sh yield%
24.91
35.99
37.99
Owners
Insiders/Inst%
6.21
32.74
Short interest%
2.46
SBC / revenue%
4.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
26–32
$1 testx
0.7
Incr. ROIC%
4